E. Dolfini

1.2k total citations
61 papers, 1.0k citations indexed

About

E. Dolfini is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, E. Dolfini has authored 61 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 13 papers in Oncology. Recurrent topics in E. Dolfini's work include Drug Transport and Resistance Mechanisms (11 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Neuroscience and Neuropharmacology Research (6 papers). E. Dolfini is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Neuroscience and Neuropharmacology Research (6 papers). E. Dolfini collaborates with scholars based in Italy and United States. E. Dolfini's co-authors include A. Jori, Silvio Garattini, L. Valzelli, Annarica Calcabrini, Giuseppe Arancia, Elena Monti, Stefania Meschini, M.G. Donelli, Teresa Dasdia and Maria Teresa Bardella and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Journal of Medicinal Chemistry and British Journal of Cancer.

In The Last Decade

E. Dolfini

59 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Dolfini Italy 22 325 214 207 110 103 61 1.0k
Laura Revel Italy 17 266 0.8× 106 0.5× 356 1.7× 53 0.5× 170 1.7× 44 806
Tadashi Hashimoto Japan 19 584 1.8× 105 0.5× 332 1.6× 38 0.3× 157 1.5× 81 1.6k
M Dubrasquet France 17 307 0.9× 93 0.4× 341 1.6× 124 1.1× 307 3.0× 83 987
T. M. Chang United States 23 330 1.0× 113 0.5× 468 2.3× 261 2.4× 430 4.2× 45 1.3k
Markus Sjöblom Sweden 23 342 1.1× 249 1.2× 63 0.3× 152 1.4× 131 1.3× 63 1.3k
Jo Mori Japan 17 346 1.1× 65 0.3× 210 1.0× 48 0.4× 75 0.7× 66 945
Ryo Tanaka Japan 16 524 1.6× 110 0.5× 116 0.6× 73 0.7× 130 1.3× 42 1.0k
Kiyoshi Takasuna Japan 19 697 2.1× 382 1.8× 204 1.0× 20 0.2× 88 0.9× 56 1.2k
Giovanna Casili Italy 25 666 2.0× 142 0.7× 152 0.7× 76 0.7× 140 1.4× 92 1.6k
Ryuichi Ishida Japan 21 416 1.3× 30 0.1× 216 1.0× 45 0.4× 109 1.1× 76 1.1k

Countries citing papers authored by E. Dolfini

Since Specialization
Citations

This map shows the geographic impact of E. Dolfini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Dolfini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Dolfini more than expected).

Fields of papers citing papers by E. Dolfini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Dolfini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Dolfini. The network helps show where E. Dolfini may publish in the future.

Co-authorship network of co-authors of E. Dolfini

This figure shows the co-authorship network connecting the top 25 collaborators of E. Dolfini. A scholar is included among the top collaborators of E. Dolfini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Dolfini. E. Dolfini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roncoroni, Leda, Luca Elli, E. Dolfini, et al.. (2008). Resveratrol inhibits cell growth in a human cholangiocarcinoma cell line. Liver International. 28(10). 1426–1436. 29 indexed citations
2.
Dolfini, E.. (2005). Damaging effects of gliadin on three-dimensional cell culture model. World Journal of Gastroenterology. 11(38). 5973–5973. 28 indexed citations
3.
Dolfini, E.. (2005). Cytoskeleton reorganization and ultrastructural damage induced by gliadin in a three-dimensional in vitro model. World Journal of Gastroenterology. 11(48). 7597–7597. 30 indexed citations
4.
Meschini, Stefania, Manuela Marra, Annarica Calcabrini, et al.. (2002). Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells. Toxicology in Vitro. 16(4). 389–398. 59 indexed citations
5.
Dolfini, E., Luca Elli, Teresa Dasdia, et al.. (2002). In vitro cytotoxic effect of bread wheat gliadin on the LoVo human adenocarcinoma cell line. Toxicology in Vitro. 16(4). 331–337. 24 indexed citations
6.
Dasdia, Teresa, Luca Bottero, Roberto Buffa, et al.. (1998). Organ culture in 3-dimensional matrix:In vitro model for evaluating biological compliance of synthetic meshes for abdominal wall repair. Journal of Biomedical Materials Research. 43(2). 204–209. 21 indexed citations
7.
Porta, Caterina A. M. La, E. Dolfini, & Roberto Comolli. (1998). Inhibition of protein kinase C-α isoform enhances the P-glycoprotein expression and the survival of LoVo human colon adenocarcinoma cells to doxorubicin exposure. British Journal of Cancer. 78(10). 1283–1287. 20 indexed citations
8.
Dolfini, E., Teresa Dasdia, Giuseppe Arancia, et al.. (1997). Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin. British Journal of Cancer. 76(1). 67–76. 29 indexed citations
9.
Conforti, G, A.M. Codegoni, Eugenio Scanziani, et al.. (1995). Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin. British Journal of Cancer. 71(3). 505–511. 16 indexed citations
10.
Belvedere, G. & E. Dolfini. (1994). Studies on low-level MDR cells. PubMed. 12(1-3). 257–264. 3 indexed citations
11.
Belvedere, G. & E. Dolfini. (1993). Studies on low-level MDR cells. Cytotechnology. 12(1-3). 257–264. 2 indexed citations
12.
Dolfini, E., et al.. (1993). Analysis of calcium-dependent protein kinase-C isoenzymes in intrinsically resistant cloned lines of LoVo cells: reversal of resistance by kinase inhibitor 1-(5-isoquinolinylsulfonyl) 2-methylpiperazine.. PubMed. 13(4). 1123–7. 12 indexed citations
13.
Dolfini, E., et al.. (1983). Human lymphocytes/freeze-dried microsomes an improved method for short-term mutagenesis and carcinogenesis testing. Mutation Research Letters. 120(4). 277–280. 3 indexed citations
14.
Vaghi, Massimo, S. Algeri, N. Brunello, et al.. (1982). Studies on a neuronal-like transport system for serotonin in two cell lines. Pharmacological Research Communications. 14(9). 851–859. 1 indexed citations
15.
Dolfini, E., Bruno Azzarone, Emerenziana Ottaviano, et al.. (1976). Characterization of human fibroblasts from cancer patients: Loss of fibrin clot retractile activity after ‘in vitro’ spontaneous transformation. European Journal of Cancer (1965). 12(10). 823–825. 19 indexed citations
16.
Dolfini, E., et al.. (1976). Synthesis and anticancer activity of 5-diethylaminomethyl derivatives and nitrogen mustards of uracil and 2-thiouracils. Journal of Medicinal Chemistry. 19(5). 639–642. 8 indexed citations
17.
Jori, A. & E. Dolfini. (1974). On the effect of anorectic drugs on striatum homovanillic acid in rats. Pharmacological Research Communications. 6(2). 175–178. 13 indexed citations
18.
Morasca, L., et al.. (1972). Evaluation of the adhesion to glass of mammalian cells by an electronic particle counter. Cellular and Molecular Life Sciences. 28(10). 1263–1264.
19.
Dolfini, E., Silvio Garattini, & L. Valzelli. (1969). Different sensitivity to amphetamine of three strains of mice. European Journal of Pharmacology. 7(2). 220–223. 15 indexed citations
20.
Dolfini, E. & Mitsuru Kobayashi. (1967). Studies with amphetamine in hyper- and hypothyroid rats. European Journal of Pharmacology. 2(1). 65–66. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Revel Breakdown of academic impact, for papers by Tadashi Hashimoto Breakdown of academic impact, for papers by M Dubrasquet Breakdown of academic impact, for papers by T. M. Chang Breakdown of academic impact, for papers by Markus Sjöblom Breakdown of academic impact, for papers by Jo Mori Breakdown of academic impact, for papers by Ryo Tanaka Breakdown of academic impact, for papers by Kiyoshi Takasuna Breakdown of academic impact, for papers by Giovanna Casili Breakdown of academic impact, for papers by Ryuichi Ishida
Rankless by CCL
2026